ProQuest Associates IV LLC 13F Holdings · last filed Q3 2018
ProQuest Associates IV LLC reported 4 securities worth $52.96M in its SEC 13F filing for Q3 2018 (period ended 2018-09-30). Top holdings: URGN (70.39%), MRSN (18.05%), IMDZ (8.06%). Among its top 25 positions this quarter: 1 exited.
| Rank | Ticker | Company | Value | % Portfolio | Shares | Action |
|---|---|---|---|---|---|---|
| 1 | URGN | UROGEN PHARMA LTD. | $37.3M | 70.39% | 789,297 | Hold |
| 2 | MRSN | MERSANA THERAPEUTICS, INC. | $9.6M | 18.05% | 955,709 | Hold |
| 3 | IMDZ | IMMUNE DESIGN CORP. | $4.3M | 8.06% | 1.2M | Hold |
| 4 | AGRX | AGILE THERAPEUTICS, INC. | $1.9M | 3.50% | 5.1M | Hold |
| 5 | EGRX | EAGLE PHARMACEUTICALS, INC. | $0 | 0.00% | 0 | Exited |
Source: SEC Form 13F filings · as of 2018-09-30
Every position in this 13F-HR, with its change from the prior quarter.
13F holdings, latest quarter
SourceSEC EDGAR13F-HR